Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Schlomm

Showing results (101-110 of 359) with videos related to

Pageof 36
Sort By:
Urology|December 5, 2006
Development and internal validation of preoperative transition zone prostate cancer nomogramThomas Steuber, Felix K-H Chun, Andreas Erbersdobler, et al.
Scientific Reports|February 26, 2020
Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate CancerJan K Hennigs, Sarah Minner, Pierre Tennstedt, et al.
European Urology|April 28, 2015
Genomic Predictors of Outcome in Prostate CancerPeter J Boström, Anders S Bjartell, James W F Catto, et al.
Journal of Clinical Medicine|September 13, 2025
Long-Term Outcomes of Living Kidney Donors Left with Multiple Renal Arteries: A Retrospective Cohort Study from a Single CenterThomas Kurz, Jacob Schmidt, Isabel Lichy, et al.
Experimental and Therapeutic Medicine|December 20, 2012
High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancerFrank Jacobsen, Sharad Nouraie Ashtiani, Pierre Tennstedt, et al.
BJU International|October 17, 2013
Incremental detection rate of prostate cancer by real-time elastography targeted biopsies in combination with a conventional 10-core biopsy in 1024 consecutive patientsGeorg Salomon, Nils Drews, Philippe Autier, et al.
European Urology|January 14, 2014
A feasible and time-efficient adaptation of NeuroSAFE for da Vinci robot-assisted radical prostatectomyBurkhard Beyer, Thorsten Schlomm, Pierre Tennstedt, et al.
Plos One|July 11, 2014
Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapseJan K Hennigs, Julia Müller, Matti Adam, et al.
International Journal of Oncology|September 30, 2011
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkersPierre Tennstedt, Patricia Köster, Andreas Brüchmann, et al.
BJU International|October 16, 2016
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomyDerya Tilki, Felix Preisser, Pierre Tennstedt, et al.
Pageof 36

Showing results (101-110 of 359) with videos related to

Sort By:
Pageof 36
Urology|December 5, 2006
Development and internal validation of preoperative transition zone prostate cancer nomogramThomas Steuber, Felix K-H Chun, Andreas Erbersdobler, et al.
Scientific Reports|February 26, 2020
Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate CancerJan K Hennigs, Sarah Minner, Pierre Tennstedt, et al.
European Urology|April 28, 2015
Genomic Predictors of Outcome in Prostate CancerPeter J Boström, Anders S Bjartell, James W F Catto, et al.
Journal of Clinical Medicine|September 13, 2025
Long-Term Outcomes of Living Kidney Donors Left with Multiple Renal Arteries: A Retrospective Cohort Study from a Single CenterThomas Kurz, Jacob Schmidt, Isabel Lichy, et al.
Experimental and Therapeutic Medicine|December 20, 2012
High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancerFrank Jacobsen, Sharad Nouraie Ashtiani, Pierre Tennstedt, et al.
BJU International|October 17, 2013
Incremental detection rate of prostate cancer by real-time elastography targeted biopsies in combination with a conventional 10-core biopsy in 1024 consecutive patientsGeorg Salomon, Nils Drews, Philippe Autier, et al.
European Urology|January 14, 2014
A feasible and time-efficient adaptation of NeuroSAFE for da Vinci robot-assisted radical prostatectomyBurkhard Beyer, Thorsten Schlomm, Pierre Tennstedt, et al.
Plos One|July 11, 2014
Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapseJan K Hennigs, Julia Müller, Matti Adam, et al.
International Journal of Oncology|September 30, 2011
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkersPierre Tennstedt, Patricia Köster, Andreas Brüchmann, et al.
BJU International|October 16, 2016
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomyDerya Tilki, Felix Preisser, Pierre Tennstedt, et al.
Pageof 36